“life-sciences” Archives

in
Entry Author Date Location
Healthcare + A.I. at Pfizer on Nov. 2: Here’s the Agenda 10/13/17 Boston
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote 10/12/17 New York
OrthoPediatrics IPO Raises $52M for Medical Implants and Instruments 10/12/17 Indiana
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
Promega, CEO Linton Return Fire in Legal Battle with Shareholders 10/11/17 Wisconsin
Zafgen Names Hatfield CEO, Former Chief Exec Hughes Shifts to CSO 10/11/17 Boston
Armo BioSciences Appoints Joseph Leveque Chief Medical Officer 10/11/17 San Francisco
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Q&A: Xconomy Award Winner Rob Perez On How Boston Biotech Can Get Involved With The Community 10/10/17 Boston
Healthcare is Ready for Alexa, as Soon as HIPAA Issue Resolved 10/10/17 Seattle
Ag Secretary Perdue Hears Startups Call for More Research Support 10/06/17 Raleigh Durham
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Boston’s Life Science Disruptors: The Photos 10/05/17 Boston
Texas Bio and Tech Hub Looks to Help Global Startups Gain Velocity 10/05/17 Texas
Indiana Center for Biomedical Innovation Aims to Get Ideas to Market 10/05/17 Indiana
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Invenra, Developer of Therapeutic Antibodies, Raises $2.9M 10/05/17 Wisconsin
Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing 10/05/17 Detroit Ann Arbor
Fresenius Medical’s Angelo Moesslang Joins InGeneron as CEO 10/04/17 Texas
Impel NeuroPharma Names Jon Congleton President and CEO 10/04/17 Seattle
Xconomy Award Winner Lita Nelsen Reflects on a Career in Tech Transfer: Q&A 10/04/17 Boston
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
Amicus Therapeutics’ Pompe Drug Data Show Improved Muscle Movement 10/04/17 New York
Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition 10/03/17 San Francisco
Celebrating Boston Life Sciences: Xconomy Awards Gala Slideshow 10/03/17 Boston
Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio 10/03/17 Boston
Genomics Startup Sema4 Appoints Jamie Coffin President and COO 10/02/17 New York
Page 4 of 341 « previous page · next page »